Compounds and compositions as kinase inhibitors
US8518931B2 · kind B2 · utility
6Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2009 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | Oct 28, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to triazine and pyrimidine derivatives having Formula (1) or (2), and methods for using such compounds. For example, the compounds of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-IR), and/or insulin receptor (InsR) or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.